Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: real-world evidence from Germany

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: März, Winfried (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Atherosclerosis
Year: 2017, Jahrgang: 268, Pages: 99-107
ISSN:1879-1484
DOI:10.1016/j.atherosclerosis.2017.11.020
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.atherosclerosis.2017.11.020
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0021915017313904
Volltext
Verfasserangaben:Winfried März, Franz-Werner Dippel, Karlheinz Theobald, Katherine Gorcyca, Şerban R. Iorga, David Ansell

MARC

LEADER 00000caa a2200000 c 4500
001 1575769166
003 DE-627
005 20230427042913.0
007 cr uuu---uuuuu
008 180528r20182017xx |||||o 00| ||eng c
024 7 |a 10.1016/j.atherosclerosis.2017.11.020  |2 doi 
035 |a (DE-627)1575769166 
035 |a (DE-576)505769166 
035 |a (DE-599)BSZ505769166 
035 |a (OCoLC)1341010190 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a März, Winfried  |d 1958-  |e VerfasserIn  |0 (DE-588)1027603599  |0 (DE-627)729463605  |0 (DE-576)373454635  |4 aut 
245 1 0 |a Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk  |b real-world evidence from Germany  |c Winfried März, Franz-Werner Dippel, Karlheinz Theobald, Katherine Gorcyca, Şerban R. Iorga, David Ansell 
264 1 |c 2018 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 20 November 2017 
500 |a Gesehen am 28.05.2018 
534 |c 2017 
650 4 |a Cardiovascular diseases 
650 4 |a Diabetes mellitus 
650 4 |a Germany 
650 4 |a LDL-C 
650 4 |a LDL-C goal attainment 
650 4 |a Lipid-lowering therapy 
650 4 |a Real-world evidence 
773 0 8 |i Enthalten in  |t Atherosclerosis  |d Amsterdam [u.a.] : Elsevier Science, 1970  |g 268(2018), Seite 99-107  |h Online-Ressource  |w (DE-627)306654091  |w (DE-600)1499887-7  |w (DE-576)081984545  |x 1879-1484  |7 nnas  |a Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk real-world evidence from Germany 
773 1 8 |g volume:268  |g year:2018  |g pages:99-107  |g extent:9  |a Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk real-world evidence from Germany 
856 4 0 |u http://dx.doi.org/10.1016/j.atherosclerosis.2017.11.020  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0021915017313904  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180528 
993 |a Article 
994 |a 2018 
998 |g 1027603599  |a März, Winfried  |m 1027603599:März, Winfried  |d 60000  |d 61400  |e 60000PM1027603599  |e 61400PM1027603599  |k 0/60000/  |k 1/60000/61400/  |p 1  |x j 
999 |a KXP-PPN1575769166  |e 3010542259 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"März, Winfried","role":"aut","family":"März","given":"Winfried"}],"language":["eng"],"relHost":[{"id":{"eki":["306654091"],"issn":["1879-1484"],"zdb":["1499887-7"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["Nachgewiesen 11.1970 -"],"part":{"text":"268(2018), Seite 99-107","pages":"99-107","year":"2018","extent":"9","volume":"268"},"origin":[{"publisher":"Elsevier Science","dateIssuedDisp":"[1970?]-","publisherPlace":"Amsterdam [u.a.]"}],"recId":"306654091","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Atherosclerosis","title_sort":"Atherosclerosis"}],"language":["eng"],"disp":"Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk real-world evidence from GermanyAtherosclerosis","note":["Gesehen am 14.10.2020"]}],"title":[{"title":"Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk","subtitle":"real-world evidence from Germany","title_sort":"Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk"}],"id":{"doi":["10.1016/j.atherosclerosis.2017.11.020"],"eki":["1575769166"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"9 S."}],"note":["Available online 20 November 2017","Gesehen am 28.05.2018"],"recId":"1575769166","name":{"displayForm":["Winfried März, Franz-Werner Dippel, Karlheinz Theobald, Katherine Gorcyca, Şerban R. Iorga, David Ansell"]},"origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}]} 
SRT |a MAERZWINFRUTILIZATIO2018